RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. The company specializes in developing tumor-targeted small molecule medicines that utilize radioisotopes, particularly focusing on alpha-emitting isotopes like Actinium-225 for the treatment of solid tumors. RayzeBio aims to improve cancer treatment outcomes by creating a robust pipeline of radiopharmaceuticals targeting validated oncology drug targets. Its portfolio includes multiple drug candidates at various stages of development, ranging from discovery to late-stage clinical programs, addressing significant market opportunities in the field of cancer therapeutics.
Inspirna is a biopharmaceutical company focused on discovering and developing innovative therapeutic targets and drugs for various cancer subtypes, including melanoma, colorectal cancer, and triple-negative breast cancer. Utilizing a proprietary microRNA-based target discovery platform, Inspirna identifies and validates novel post-transcriptionally regulated targets, leading to the creation of first-in-class therapeutics. The company has developed several promising drug candidates, such as RGX-104, an oral small molecule designed for treating solid tumors, RGX-202, which targets cancer metabolism in gastrointestinal cancers, and RGX-019, a monoclonal antibody aimed at disrupting pathways that promote tumor progression and metastasis. Founded in 2010 and headquartered in New York, Inspirna strives to transform the lives of cancer patients by providing safe and effective therapies for metastatic disease.
LimaCharlie is a provider of Security Infrastructure as a Service (SIaaS), offering a platform designed to streamline information security management. By delivering security tools on-demand, LimaCharlie enables businesses to efficiently manage their cloud security while significantly reducing costs and effort. The platform includes endpoint-driven security tools, telemetry storage, and a comprehensive incident response pipeline, allowing users to create custom detection and response rules. Additionally, LimaCharlie equips organizations with the necessary resources to operate a Managed Security Service Provider (MSSP) or Security Operations Center (SOC). The availability of APIs further allows users to build and monetize their own security products, making it a versatile solution in the field of information security.
Redbud Brands is a brand development studio focused on creating disruptive companies in the consumer space, particularly within the premium consumer packaged goods sector. The firm partners with visionary founders and executives, providing them with resources and services to launch and scale innovative brands. Redbud Brands emphasizes 'better-for-you' products and offers access to capital, a shared services platform featuring a network of experienced executives, and strategic relationships with retailers, distributors, and suppliers. This comprehensive support system is designed to empower entrepreneurs to build transformative and sustainable businesses that aim to make a positive impact on society.
Developer of AI governance platform designed to automate artificial intelligence oversight and risk management. The company's SaaS platform provides continuous and comprehensive regulatory compliance to measure, monitor, and manage AI-introduced risks at scale, enabling enterprises to build customer trust to unlock sales opportunities, differentiate with AI, and manage risks effectively to gain confidence in their deployments.
Speech Graphics Ltd specializes in procedural facial animation solutions for the entertainment industry, providing a unique software called SGX that transforms audio files and transcripts into high-quality facial animations without the need for motion capture. Founded in 2010 and based in Edinburgh, Scotland, the company emerged from the University of Edinburgh’s School of Informatics and has over 20 years of research and development in speech technology and facial dynamics. Speech Graphics has collaborated with notable clients, including Warner Brothers and Def Jam Recordings, and its technology is utilized in various productions, such as AAA video games and music videos, as well as in communication and training applications. The company has received multiple accolades for its innovative contributions, including the John Logie Baird Award and various industry-specific honors, alongside development grants from organizations like Scottish Enterprise.
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
Codoxo, also known as FraudScope, is a technology company that focuses on combating healthcare fraud, waste, and abuse through its artificial intelligence-based platform. Founded in 2016 and headquartered in Atlanta, Georgia, the company aims to enhance the allocation of healthcare funds by reducing fraudulent medical billing practices, which contribute to an estimated $272 billion in losses annually in the United States. Codoxo’s software platform employs advanced data analytics to detect, score, and rank suspicious claims, significantly improving upon traditional detection methods that often overlook fraud. The company's innovative Claims Intelligence technology, developed by researchers at the Georgia Institute of Technology, is capable of identifying evolving fraud schemes in real-time without relying on pre-existing fraud patterns. By utilizing data from the Centers for Medicare and Medicaid Services, Codoxo can proactively flag high-risk claims, thereby facilitating earlier interventions and ensuring healthcare resources are directed towards legitimate patient care.
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns.
Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Upgrade, Inc. is an online lending platform based in San Francisco, California, with additional offices in Phoenix, Montreal, and Chicago. Founded in 2016, the company operates as a neobank, providing access to personal loans and innovative credit products, such as the Upgrade Card, which combines the benefits of installment lending with traditional credit card usage. Upgrade focuses on offering affordable and responsible credit solutions to mainstream consumers while also providing free credit monitoring and educational resources aimed at helping individuals manage their finances effectively. Through its services, Upgrade enables consumers to gain a better understanding of their credit health and make informed financial decisions.
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.
Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on developing oncology medicines tailored to individual patients. The company employs a proteomics-based platform to identify patients whose tumors are likely to respond to specific treatments, thereby enhancing the effectiveness of drug development. Acrivon's lead program is ACR-368, also known as prexasertib, which is currently in Phase 2 trials. Additionally, the pipeline includes preclinical programs that target critical components of the DNA Damage Response and cell cycle regulation pathways, specifically focusing on proteins such as WEE1 and PKMYT1. By leveraging these innovative approaches, Acrivon aims to improve therapeutic outcomes for cancer patients.
SafeBreach Inc. is a cybersecurity company that specializes in breach and attack simulation, providing organizations with tools to enhance their security posture. Founded in 2014 and based in Sunnyvale, California, with an additional location in Tel Aviv, Israel, SafeBreach offers a comprehensive platform that simulates hacker techniques to identify vulnerabilities within a network. Its platform utilizes an extensive Hacker's Playbook, which includes real-world breach methods, to proactively predict potential attacks and validate existing security controls. By integrating with various security information and event management systems and other cybersecurity tools, SafeBreach enables continuous visibility into security issues, allowing businesses to detect and remediate potential breaches before they can be exploited by actual attackers. The company is supported by notable investors, including Sequoia Capital and Deutsche Telekom Capital.
Mekonos Inc. is a technology company based in San Francisco, California, focused on the design, development, and production of gene and cell therapies. Founded in 2017, Mekonos has developed a proprietary cell-engineering platform that utilizes scalable silicon technology and an integrated system-on-a-chip. This platform enables the creation of predictive models for drug discovery and development, as well as a silicon chip automated architecture for genome editing. The company's innovative MEMS technology allows for the precise control of individual nanoneedles to inject single cells in parallel, facilitating the industrialization of engineered therapies for genetic diseases, including cancers. By providing a reliable and reusable manufacturing system, Mekonos aims to enable healthcare providers to deliver a diverse range of therapeutic molecules across various primary cell types.
SafeRide, Inc. is a digital health platform that specializes in non-emergency medical transportation (NEMT) services, enabling healthcare providers to efficiently book and manage rides for patients. Founded in 2015 and headquartered in San Francisco, the company offers a mobile application that allows users to schedule transportation quickly, receive appointment reminders, and track rides in real-time for enhanced safety and quality. SafeRide's services not only help prevent no-shows but also assist in identifying and managing at-risk patients before their conditions worsen. With a network that spans major cities including Los Angeles, Seattle, Portland, St. Louis, and New York, SafeRide aims to improve access to life-sustaining care for vulnerable populations while enhancing the overall patient experience and reducing healthcare costs.
Prilenia Therapeutics B.V., a clinical stage biotech company, researches and develops products for movement disorders and neurodegenerative diseases affecting adults and children. It offers Pridopidine, an orally bioavailable small molecule investigational drug for huntington disease, amyotrophic lateral sclerosis, Parkinson’s disease levodopa induced dyskinesia, neurodegenerative eye disease, Parkinson’s disease, rett syndrome, fragile X, and Alzheimer’s disease. The company was founded in 2018 and is based in the Netherlands.
Vesper Technologies Inc. is an electrical and electronic manufacturing company based in Boston, Massachusetts, specializing in the development and production of piezoelectric MEMS microphones. Founded in 2009, Vesper focuses on delivering innovative microphone solutions for various applications, including mobile handsets, tablets, and other audio-related products. The company's mission is to provide voice-powered solutions across diverse markets globally.
Hungry Marketplace, Inc. operates a mobile food marketplace that connects food enthusiasts with local chefs, providing a platform for ordering made-to-order meals. Founded in 2016 and based in Arlington, Virginia, the company delivers fresh-cooked meals across the District of Columbia, Maryland, and Virginia. Hungry specializes in catering by offering a diverse selection of curated menus from independent chefs, primarily serving businesses seeking quality office lunches. The company has successfully raised significant funding, with a notable Series B round led by prominent investors, enhancing its ability to expand its services. Committed to community welfare, Hungry's "Fight Against Hunger" initiative donates one meal to those in need for every two meals purchased, while its "WeRecycle" program emphasizes environmental sustainability through the use of biodegradable utensils. With plans for rapid expansion into additional U.S. cities, Hungry aims to become a significant player in the $60 billion catering market.
Elephas is a live tumor imaging diagnostics company focused on enhancing cancer treatment through personalized therapy determination. The company leverages advancements in cancer biology, multimodal microscopy, engineering, and artificial intelligence to analyze human live tumor fragments. This innovative platform aims to improve clinical decision-making for oncologists, enabling them to tailor treatments to individual patients. Additionally, Elephas seeks to accelerate drug development processes, addressing the urgent need for effective cancer therapies in a rapidly evolving healthcare landscape.
JumpCloud, Inc. operates a Directory-as-a-Service platform that centralizes and simplifies identity management for organizations. Founded in 2010 and based in Louisville, Colorado, the company offers a Software-as-a-Service solution that automates server management tasks such as user management, security, and compliance. Its platform enables IT teams to securely manage user identities and connect them to various resources, regardless of the provider, protocol, or location. By providing a cloud-based directory, JumpCloud allows organizations to authenticate, authorize, and manage users, devices, and applications efficiently. Additionally, the platform tracks critical server patches, monitors administrative activities, and generates reports on access and configurations, thereby enhancing overall security and operational efficiency.
Snyk Ltd. is a developer-focused cybersecurity company that provides a software-as-a-service platform designed to help organizations identify, fix, and monitor vulnerabilities in open-source dependencies and container images. The platform includes tools such as Snyk Code, which offers static application security testing, and container vulnerability management, which addresses vulnerabilities in Docker images. Snyk enables developers to scan their code for security issues directly within their code editors, providing alerts and remediation guidance based on an internal database of known vulnerabilities. The company also offers features for application security management, licensing compliance, and infrastructure as code security. Founded in 2015 and headquartered in London, Snyk has additional offices in Tel Aviv, Boston, and Ontario, and has established a strategic partnership with Rapid7, Inc.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.
Learn more about #paid’s creator media platform at www.hashtagpaid.com/product
DiCE Therapeutics, founded in 2013 and based in Menlo Park, California, specializes in developing a platform for the discovery of novel small molecules aimed at targets that have previously been difficult to address in the pharmaceutical sector. The company utilizes innovative technology that extends directed evolution, allowing for the direct translation of DNA-encoded information into organic compounds, thereby streamlining the traditionally labor-intensive processes of medicinal chemistry. This platform not only serves the pharmaceutical industry but also has applications in agriculture and materials sciences. The founding team includes notable figures such as Stanford Professor Pehr Harbury, who developed the core technology, and other experienced professionals from various sectors, contributing to the company's mission of transforming drug discovery and development.
Gusto is a company that provides a cloud-based platform designed for small and medium-sized businesses to manage payroll, benefits, and human resources. Founded in 2011 and headquartered in San Francisco, with an additional office in Denver, Gusto offers an array of services including payroll processing, health benefits, workers' compensation, and time tracking. The platform allows employers and employees to access payroll information from various devices, enabling features such as browsing pay stubs, reviewing tax forms, and verifying personal details. Gusto caters to a diverse clientele, including startups, coffee shops, medical practices, creative agencies, and law firms, aiming to simplify the administrative tasks associated with employee management.
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
BlackBuck is an online fleet management platform that connects shippers with fleet operators in India. By leveraging technology, it aims to enhance the logistics landscape, making it more reliable and efficient. The platform provides features such as price discovery, route optimization, in-transit tracking, and assurance of timely deliveries. This comprehensive approach not only improves operational productivity for clients but also positively impacts the broader transportation ecosystem, which is crucial for numerous livelihoods. BlackBuck is positioned to drive significant advancements in the transportation sector.
Primer Technologies, Inc. specializes in developing advanced software that employs machine learning and natural language processing to analyze extensive datasets. The company's platform is designed to read and interpret documents in multiple languages, uncover insights, and generate automated reports that rival human analysis. By facilitating the understanding of vast amounts of text data, Primer assists governments and corporations in monitoring and making sense of global information. Founded in 2015 and headquartered in San Francisco, California, Primer aims to bridge the intelligence gap for businesses and enhance their ability to respond to emerging trends in the world.
Nubank issues, administrate, processes, and transfers payments related to post-paid credit cards and equity investment in other entities. It serves clients in Brazil. The company launched its proprietary loyalty rewards program ("Nubank Rewards"), as well as a digital account ("NuConta") that is already used by more than 17 million people. In Cristina Junqueira, David Velez, and Edward Wible founded EO2 Solucoes de Pagamento on May 6, 2013 that became Nubank in on June 25, 2013. It has its headquarters in São Paulo in Brazil.
Klaviyo, Inc. is a marketing automation and email platform that specializes in helping businesses grow through effective email marketing strategies. Founded in 2012 and headquartered in Boston, Massachusetts, with an additional office in London, Klaviyo provides a comprehensive suite of tools that includes email marketing software, segmentation capabilities, analytics, and customer profiling. The platform allows users to create personalized newsletters and automated emails, such as reminders for abandoned carts and order follow-ups, without requiring extensive resources. Klaviyo integrates seamlessly with various customer data sources, enabling businesses to manage data at scale, deliver engaging experiences across multiple channels, and measure marketing outcomes effectively.
Boom Sports is a technology company whose mission is to entertain and connect sports fans through games. After building the most popular real-money pick 'em daily fantasy product (2-time EGR app of the year), we're designing and operating world-class, free-to-play, games for media, league, and pro sports team partners. Our flagship product is NBC Sports Predictor, which offers fans in all 50 states the chance to win real money based on their (free) predictions. The product has been a huge success -- hundreds of thousands of active users, a 4.8 app store rating on 2K+ reviews -- and has provided a model for others that want to maximize the value of their audience in advance of legalized sports betting. If you want to build (legal) sports gaming products for the next generation of fans, come join us! We're hiring!
Tellius, Inc., founded in 2015 and based in Reston, Virginia, offers a business analytics platform designed to enhance data-driven decision-making for enterprises. The platform employs artificial intelligence and machine learning to automate data analysis, allowing users to quickly uncover hidden correlations, trends, and anomalies. By utilizing a search-enabled interface, it supports ad hoc exploration, enabling users from various professional backgrounds to ask questions about their business data and receive immediate, insightful visualizations. Unlike traditional business intelligence tools, Tellius is built on a distributed architecture, ensuring the scale and performance needed for handling large datasets. This capability allows clients to analyze extensive records rapidly, facilitating a more efficient approach to reporting and execution.
Samumed, LLC is a biopharmaceutical company focused on small molecule drug development aimed at oncology and degenerative diseases. Founded in 2007 and based in San Diego, California, the company utilizes its expertise in Wnt pathway modulation to create therapeutics for tissue-level regeneration. Among its key products are SM04690, an intra-articular injection for treating knee osteoarthritis, and SM07883, which is designed to mitigate disease pathology. Samumed is committed to advancing regenerative medicine through its innovative platform, which seeks to improve patient health by addressing a variety of degenerative conditions.
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.
Earli is focused on transforming cancer detection and treatment by developing innovative technologies that enable early identification of tumors. The company specializes in creating synthetic biopsies, which are designed to induce cancer cells to produce non-human synthetic biomarkers. These biomarkers can be detected in biological samples such as blood, urine, or breath, allowing for the visualization of tumors that are typically too small to identify in traditional screenings. By leveraging these programmable genetic constructs, Earli aims to provide real-time data on cancer presence and progression, facilitating personalized treatment approaches and improving the chances of successful intervention. Overall, Earli's mission is to make the experience of cancer more manageable by ensuring timely detection and response.
DiCE Therapeutics, founded in 2013 and based in Menlo Park, California, specializes in developing a platform for the discovery of novel small molecules aimed at targets that have previously been difficult to address in the pharmaceutical sector. The company utilizes innovative technology that extends directed evolution, allowing for the direct translation of DNA-encoded information into organic compounds, thereby streamlining the traditionally labor-intensive processes of medicinal chemistry. This platform not only serves the pharmaceutical industry but also has applications in agriculture and materials sciences. The founding team includes notable figures such as Stanford Professor Pehr Harbury, who developed the core technology, and other experienced professionals from various sectors, contributing to the company's mission of transforming drug discovery and development.
Coagulo Medical Technologies, Inc. is a Massachusetts-based company focused on developing advanced testing systems for coagulation management. The company provides a portable and connected precision-medicine platform that enables healthcare professionals to detect, identify, and quantify the effects of various anticoagulants in whole blood. By utilizing a combination of patent-pending coagulation assays, microfluidic technology, and data analytics, Coagulo's system offers actionable results, facilitating personalized diagnosis and management of coagulation-related conditions. This innovative approach aims to improve healthcare outcomes by making coagulation testing more accessible and efficient for both providers and patients.
Uhnder Inc. is a technology company focused on developing innovative products for sensing, cognition, and communication within the Internet of Things (IoT) market. Founded in 2015 and headquartered in California, with engineering and operations in Austin and St. Louis, Uhnder specializes in a digital automotive radar-on-chip. This technology offers a more accurate and reliable alternative to traditional light detection and ranging (lidar) systems, which are commonly used in autonomous vehicles. The radar-on-chip enhances safety by helping to avoid collisions, providing alerts for potential issues, and enabling quick localization through electronic navigation fences. By improving feedback response and system automation, Uhnder aims to transform the autonomous vehicle landscape.
Papercup is a London-based company that specializes in software designed to automatically translate voice tracks in videos using advanced machine learning techniques, including bayesian neural networks and speech synthesis. This innovative technology enables video creators to produce content in their original language while allowing users to translate the videos into their preferred languages. By making video content accessible to a global audience, Papercup empowers media companies, content creators, educational institutions, and international businesses to enhance the value of their content and reach an extensive audience of up to seven billion people.
Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.
Acumen Pharmaceuticals is a biotechnology company dedicated to discovering and developing therapeutics and diagnostics for Alzheimer’s disease and related neurodegenerative conditions. Founded in 1996 and based in Livermore, California, the company focuses on creating ADDL-Select antibodies that specifically target soluble amyloid beta oligomers, which are considered major contributors to the progression of Alzheimer’s. Acumen employs a sensitivity assay to measure levels of these oligomers in cerebrospinal fluid, aiding in the selection of patients for clinical trials. The company holds a comprehensive portfolio of patents and intellectual property related to amyloid beta soluble oligomers. It has formed a partnership with Merck & Co. for the development of certain monoclonal antibody therapeutics. Additionally, Acumen has attracted investments from firms such as NeuroVentures LLC and Biotechnology Value Fund LP.
Scopely, Inc. is a global interactive entertainment company specializing in the development and publishing of mobile games for both casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely offers a diverse portfolio of immersive gaming experiences based on original and popular franchises, including titles such as Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, and The Walking Dead: Road To Survival. The company is recognized for its innovative approach, having been featured in Fast Company’s ‘World’s Most Innovative Companies’ and ranked among the fastest-growing companies in North America. Scopely has achieved over $1 billion in lifetime revenue by focusing on long-lasting game experiences. It operates globally with studios in various locations, including Los Angeles, Barcelona, Dublin, and Tokyo, and provides services in game design, marketing, analytics, and live operations through its proprietary technology platform.
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses.
It was founded in 2017 and is based in Cambridge, Massachusetts.
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses.
It was founded in 2017 and is based in Cambridge, Massachusetts.
Private Equity Round in 2020
BYJU'S is a leading ed-tech company valued at approximately USD 10.5 billion, known for its innovative learning solutions tailored for students from classes 1 to 12 and for competitive exams such as JEE, NEET, CAT, and IAS. The flagship product, BYJU’S - The Learning App, was launched in 2015 and has since attracted over 42 million registered users, who spend an average of 71 minutes daily engaging with the platform. The app employs a variety of educational methods, including watch-and-learn videos, animations, and interactive simulations, to provide a personalized and effective learning experience. In 2019, BYJU'S expanded its offerings with the Disney. BYJU'S Early Learn App for younger students, and also acquired Osmo, enhancing its capabilities in transforming offline educational experiences into engaging online formats. BYJU'S continues to redefine learning through its adaptive and interactive approach, catering to a diverse student base across more than 1,700 cities.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
Taysha Gene Therapies is a company focused on developing adeno-associated virus (AAV) based gene therapies aimed at treating monogenic diseases of the central nervous system. Founded in 2019 and based in Dallas, Texas, the company is advancing several therapeutic candidates, including TSHA-101 for GM2 gangliosidosis, TSHA-118 for CLN1 disease, TSHA-102 for Rett syndrome, TSHA-103 for SLC6A1 haploinsufficiency disorder, and TSHA-104 for Surfeit locus 1 deficiency. Taysha Gene Therapies collaborates with The University of Texas Southwestern Medical Center to enhance the development and commercialization of its innovative treatments, with a mission to eradicate severe and life-threatening CNS diseases through curative gene therapies. The company's expertise in drug development and its partnership with a leading gene therapy program enable it to effectively progress its pipeline of potential therapies.
Thrive Earlier Detection Corp. is a healthcare company dedicated to improving cancer detection through innovative technology. It focuses on the development of CancerSEEK, a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma to identify multiple types of cancer at their earliest stages, often before symptoms become apparent. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate early cancer detection into routine medical care. The company was previously known as Thrive Sciences Inc. and has been a subsidiary of Exact Sciences Corporation since early 2021. Thrive was launched with support from various investors, including Third Rock Ventures and Section 32, reflecting a strong commitment to advancing cancer diagnostics.
ArcherDX, Inc. is a genomics company based in Boulder, Colorado, focused on advancing molecular pathology through next-generation sequencing technology. Established in 2013, the company develops and commercializes a range of research products, including DNA-based VariantPlex, RNA-based FusionPlex, ctDNA-based LiquidPlex, and RNA-based Immunoverse, aimed at optimizing therapy and monitoring cancer. ArcherDX also creates in-vitro diagnostic products and offers customizable assay design services to clinical and biopharmaceutical clients, enabling the development of new applications tailored to specific biomarker targets. The Archer platform utilizes proprietary Anchored Multiplexed PCR (AMP™) chemistry and sophisticated bioinformatics to enhance genetic mutation detection significantly. The company's products and services are utilized by academic and reference laboratories, biopharmaceutical firms, and contract research organizations, with ongoing efforts to gain regulatory approval for various companion diagnostic assays. As of October 2020, ArcherDX operates as a subsidiary of Invitae Corporation.
Scopely, Inc. is a global interactive entertainment company specializing in the development and publishing of mobile games for both casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely offers a diverse portfolio of immersive gaming experiences based on original and popular franchises, including titles such as Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, and The Walking Dead: Road To Survival. The company is recognized for its innovative approach, having been featured in Fast Company’s ‘World’s Most Innovative Companies’ and ranked among the fastest-growing companies in North America. Scopely has achieved over $1 billion in lifetime revenue by focusing on long-lasting game experiences. It operates globally with studios in various locations, including Los Angeles, Barcelona, Dublin, and Tokyo, and provides services in game design, marketing, analytics, and live operations through its proprietary technology platform.
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.
DoorDash, Inc. is a logistics platform that connects merchants, consumers, and delivery personnel in the United States and internationally. Founded in 2013 and headquartered in San Francisco, the company facilitates restaurant food delivery services, allowing customers to order from local and national eateries through its app. DoorDash operates a marketplace that helps merchants enhance their online presence, manage customer acquisition, and streamline delivery processes. In addition to food delivery, the platform serves various businesses, including grocery, retail, and pet supply stores. The company has expanded its services into Europe through the acquisition of Wolt in 2022, reinforcing its commitment to building last-mile delivery infrastructure and transforming local commerce.
BlackBuck is an online fleet management platform that connects shippers with fleet operators in India. By leveraging technology, it aims to enhance the logistics landscape, making it more reliable and efficient. The platform provides features such as price discovery, route optimization, in-transit tracking, and assurance of timely deliveries. This comprehensive approach not only improves operational productivity for clients but also positively impacts the broader transportation ecosystem, which is crucial for numerous livelihoods. BlackBuck is positioned to drive significant advancements in the transportation sector.
UiPath develops and provides robotic process automation software designed to enhance operational efficiency across various industries. The company offers a comprehensive platform for hyper automation, enabling enterprises to discover, build, manage, and optimize automation opportunities. Key products include UiPath Studio, which allows users to design automation processes with an intuitive graphical interface, and UiPath Orchestrator, which manages automation workflows and deployments. UiPath’s solutions cater to a variety of sectors, including finance, healthcare, insurance, and telecommunications, facilitating the automation of tasks such as accounts payable, claims processing, and customer service. Founded in 2005 and headquartered in New York, UiPath also has offices in several major cities worldwide, including London, Bucharest, and Tokyo. The company focuses on integrating advanced technologies, such as artificial intelligence, to streamline processes and improve business outcomes.
UiPath develops and provides robotic process automation software designed to enhance operational efficiency across various industries. The company offers a comprehensive platform for hyper automation, enabling enterprises to discover, build, manage, and optimize automation opportunities. Key products include UiPath Studio, which allows users to design automation processes with an intuitive graphical interface, and UiPath Orchestrator, which manages automation workflows and deployments. UiPath’s solutions cater to a variety of sectors, including finance, healthcare, insurance, and telecommunications, facilitating the automation of tasks such as accounts payable, claims processing, and customer service. Founded in 2005 and headquartered in New York, UiPath also has offices in several major cities worldwide, including London, Bucharest, and Tokyo. The company focuses on integrating advanced technologies, such as artificial intelligence, to streamline processes and improve business outcomes.
908 Devices Inc. is a Boston-based company that develops and sells advanced measurement devices for chemical and biochemical analysis, utilizing mass spectrometry technology. The company's product lineup includes handheld and desktop devices designed for immediate, on-site analysis across various fields such as life sciences, bioprocessing, industrial biotechnology, and forensics. Notable products include the MX908, a portable mass spectrometry device for rapid analysis of unknown substances, the Rebel desktop analyzer for real-time monitoring of bioprocess environments, and the ZipChip, a high-resolution separation platform that enhances mass spectrometry sample analysis. Established in 2012, 908 Devices aims to make mass spectrometry accessible beyond traditional laboratories, providing reliable tools for professionals needing quick and actionable insights. The company operates mainly in the United States while also serving markets in Europe, Asia, and beyond.
Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.
Hungry Marketplace, Inc. operates a mobile food marketplace that connects food enthusiasts with local chefs, providing a platform for ordering made-to-order meals. Founded in 2016 and based in Arlington, Virginia, the company delivers fresh-cooked meals across the District of Columbia, Maryland, and Virginia. Hungry specializes in catering by offering a diverse selection of curated menus from independent chefs, primarily serving businesses seeking quality office lunches. The company has successfully raised significant funding, with a notable Series B round led by prominent investors, enhancing its ability to expand its services. Committed to community welfare, Hungry's "Fight Against Hunger" initiative donates one meal to those in need for every two meals purchased, while its "WeRecycle" program emphasizes environmental sustainability through the use of biodegradable utensils. With plans for rapid expansion into additional U.S. cities, Hungry aims to become a significant player in the $60 billion catering market.
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
Karuna Pharmaceuticals, Inc. engages in development of drugs for the treatment of schizophrenia. The company was incorporated in 2009 and is based in Boston, Massachusetts.
PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.
Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Allvision IO, Inc. is a software company based in Pittsburgh, Pennsylvania, founded in 2017. It specializes in developing a platform that aggregates various sources of three-dimensional data, utilizing machine learning and cloud computing to provide actionable insights. The company's offerings include high-definition, time-based maps for mobility, infrastructure, and transportation, as well as tools for asset detection, tracking, and compliance analysis. By enabling street-level analytics on a global scale, Allvision aims to connect decision-makers across industries such as transportation, engineering, government, and insurance with valuable spatial data, helping them address complex challenges and make informed decisions.
SeLux Diagnostics, Inc. is focused on advancing antibiotic susceptibility testing and infectious disease diagnostics through its innovative phenotyping platform. Founded in 2014 and located in Charlestown, Massachusetts, the company employs a unique synthetic amplifier technology that enhances the speed and complexity of antibiotic susceptibility testing. This platform significantly improves the accuracy and timeliness of diagnosing infections, enabling healthcare providers to prescribe targeted and personalized antibiotic therapies. By facilitating informed treatment decisions, SeLux Diagnostics aims to enhance patient care, save lives, and improve overall health outcomes in hospital settings.
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.
Acumen Pharmaceuticals is a biotechnology company dedicated to discovering and developing therapeutics and diagnostics for Alzheimer’s disease and related neurodegenerative conditions. Founded in 1996 and based in Livermore, California, the company focuses on creating ADDL-Select antibodies that specifically target soluble amyloid beta oligomers, which are considered major contributors to the progression of Alzheimer’s. Acumen employs a sensitivity assay to measure levels of these oligomers in cerebrospinal fluid, aiding in the selection of patients for clinical trials. The company holds a comprehensive portfolio of patents and intellectual property related to amyloid beta soluble oligomers. It has formed a partnership with Merck & Co. for the development of certain monoclonal antibody therapeutics. Additionally, Acumen has attracted investments from firms such as NeuroVentures LLC and Biotechnology Value Fund LP.
BlackBuck is an online fleet management platform that connects shippers with fleet operators in India. By leveraging technology, it aims to enhance the logistics landscape, making it more reliable and efficient. The platform provides features such as price discovery, route optimization, in-transit tracking, and assurance of timely deliveries. This comprehensive approach not only improves operational productivity for clients but also positively impacts the broader transportation ecosystem, which is crucial for numerous livelihoods. BlackBuck is positioned to drive significant advancements in the transportation sector.
NanoView Biosciences is a biotechnology company based in Boston, Massachusetts, specializing in the characterization of extracellular vesicles, particularly exosomes. Utilizing its proprietary ExoView technology, the company provides high-throughput, cost-effective analysis solutions that facilitate the detection and multiparametric characterization of exosomes from complex biological samples such as whole blood, serum, plasma, and urine. NanoView Biosciences offers a range of products, including the ExoView R100 and ExoView Tetraspanin, as well as custom assays and sample services. The company's innovations support research and the advancement of precision medicine, enabling life science researchers to gain insights into the biological roles of exosomes as potential biomarkers for disease diagnosis, treatment, and monitoring. Founded in 2015, NanoView Biosciences is committed to enhancing the understanding of exosomes in the context of health and disease.
Upgrade, Inc. is an online lending platform based in San Francisco, California, with additional offices in Phoenix, Montreal, and Chicago. Founded in 2016, the company operates as a neobank, providing access to personal loans and innovative credit products, such as the Upgrade Card, which combines the benefits of installment lending with traditional credit card usage. Upgrade focuses on offering affordable and responsible credit solutions to mainstream consumers while also providing free credit monitoring and educational resources aimed at helping individuals manage their finances effectively. Through its services, Upgrade enables consumers to gain a better understanding of their credit health and make informed financial decisions.
Slack Technologies, Inc. operates a business communication platform that enhances collaboration among teams by integrating messaging, voice and video calls, file sharing, and workflow automation. Founded in 2009 and headquartered in San Francisco, California, Slack serves a diverse clientele ranging from Fortune 100 companies to small businesses, aiming to streamline communication and improve productivity. The platform is delivered as a software-as-a-service solution, allowing users to connect with the right people and information efficiently. Additionally, Slack has established the Slack Fund, an investment initiative focused on early-stage ventures in the technology sector, further promoting innovation in workplace productivity tools.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
Vesper Technologies Inc. is an electrical and electronic manufacturing company based in Boston, Massachusetts, specializing in the development and production of piezoelectric MEMS microphones. Founded in 2009, Vesper focuses on delivering innovative microphone solutions for various applications, including mobile handsets, tablets, and other audio-related products. The company's mission is to provide voice-powered solutions across diverse markets globally.
Neptune Financial (NepFin) is a next-generation financial services company whose commercial lending platform provides growth capital to mid-sized American businesses. With its team's experience in technology, traditional leveraged finance, and online lending, the company is poised to transform the way that middle-market borrowers access debt financing. Based in San Francisco, NepFin is supported by the same early investors as SoFi, Funding Circle, Lending Club and Upgrade. For more information please visit www.nepfin.com.
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.
Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
Avitide, Inc. specializes in the discovery, manufacturing, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. The company focuses on developing customized affinity separation technology that streamlines bioprocess development, minimizes program risks, enhances predictability in commercial scalability, and lowers manufacturing costs. Its innovative affinity purification solutions cater to the production of various life-saving therapeutics, including enzymes, novel scaffolds, multi-specific antibodies, gene therapies, and vaccines. Incorporated in 2012 and based in Lebanon, New Hampshire, Avitide is recognized for its rapid development service timeline, positioning itself as a key player in the biopharmaceutical sector.
Scopely, Inc. is a global interactive entertainment company specializing in the development and publishing of mobile games for both casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely offers a diverse portfolio of immersive gaming experiences based on original and popular franchises, including titles such as Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, and The Walking Dead: Road To Survival. The company is recognized for its innovative approach, having been featured in Fast Company’s ‘World’s Most Innovative Companies’ and ranked among the fastest-growing companies in North America. Scopely has achieved over $1 billion in lifetime revenue by focusing on long-lasting game experiences. It operates globally with studios in various locations, including Los Angeles, Barcelona, Dublin, and Tokyo, and provides services in game design, marketing, analytics, and live operations through its proprietary technology platform.
BlackBuck is an online fleet management platform that connects shippers with fleet operators in India. By leveraging technology, it aims to enhance the logistics landscape, making it more reliable and efficient. The platform provides features such as price discovery, route optimization, in-transit tracking, and assurance of timely deliveries. This comprehensive approach not only improves operational productivity for clients but also positively impacts the broader transportation ecosystem, which is crucial for numerous livelihoods. BlackBuck is positioned to drive significant advancements in the transportation sector.
Upgrade, Inc. is an online lending platform based in San Francisco, California, with additional offices in Phoenix, Montreal, and Chicago. Founded in 2016, the company operates as a neobank, providing access to personal loans and innovative credit products, such as the Upgrade Card, which combines the benefits of installment lending with traditional credit card usage. Upgrade focuses on offering affordable and responsible credit solutions to mainstream consumers while also providing free credit monitoring and educational resources aimed at helping individuals manage their finances effectively. Through its services, Upgrade enables consumers to gain a better understanding of their credit health and make informed financial decisions.
Agilis Biotherapeutics, LLC is engaged in developing DNA therapeutics aimed at treating rare central nervous system (CNS) diseases caused by single-gene defects. The company's innovative technology focuses on precisely targeting and restoring lost gene function while minimizing off-target effects. Agilis offers treatments for conditions such as AADC Deficiency, which impairs motor strength and control due to reduced levels of the enzyme aromatic L-amino acid decarboxylase, and Friedreich’s Ataxia, a severe neurodegenerative disease linked to a defect in the FXN gene that reduces frataxin protein production. Additionally, the company develops therapies for Angelman Syndrome, characterized by significant developmental delays. Founded in 2013 and headquartered in Cambridge, Massachusetts, Agilis Biotherapeutics has established a strategic partnership with Intrexon Corporation and operates as a subsidiary of PTC Therapeutics, Inc.
Funding Circle is a London-based online lending platform established in 2010 that connects investors with small and medium-sized businesses seeking capital. Operating in the United Kingdom, the United States, Germany, the Netherlands, and Spain, Funding Circle facilitates direct lending through its marketplace, allowing a variety of investors—including individuals, banks, local councils, and institutional investors—to fund business loans. The platform offers both secured and unsecured loans to help businesses with various financial needs, such as working capital, asset purchases, and property development. Additionally, Funding Circle collaborates with institutional investors on securitization programs and issues loan payment dependent debt securities. By bridging the gap between businesses in need of funding and investors seeking attractive returns, Funding Circle aims to create a mutually beneficial relationship that supports economic growth and job creation.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
Scopely, Inc. is a global interactive entertainment company specializing in the development and publishing of mobile games for both casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely offers a diverse portfolio of immersive gaming experiences based on original and popular franchises, including titles such as Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, and The Walking Dead: Road To Survival. The company is recognized for its innovative approach, having been featured in Fast Company’s ‘World’s Most Innovative Companies’ and ranked among the fastest-growing companies in North America. Scopely has achieved over $1 billion in lifetime revenue by focusing on long-lasting game experiences. It operates globally with studios in various locations, including Los Angeles, Barcelona, Dublin, and Tokyo, and provides services in game design, marketing, analytics, and live operations through its proprietary technology platform.
Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.
AppDynamics is a developer of an observability platform focused on application performance management and mobile analytics. The platform is designed to provide real-time insights into application performance, user interactions, and overall business performance. By dynamically collecting millions of performance data points across applications and infrastructure, it enables organizations to proactively monitor and optimize complex software environments. AppDynamics employs advanced analytics to instantly identify performance anomalies and facilitate automatic fixes, ensuring continuous measurement of business impact. This capability is delivered in real-time, allowing for flexibility in deployment across cloud or on-premise environments. The emphasis on user interactions enhances customer engagement and improves operational efficiency, positioning AppDynamics as a critical tool for software-defined businesses seeking to enhance their digital performance.
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.